Last update 08 Feb 2025

TY-0540

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
TY-0540, TYK 00540, TYK-00540
+ [1]
Target
CDK2 x CDK4 x CDK6
Mechanism
CDK2 inhibitors(Cyclin-dependent kinase 2 inhibitors), CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication
Locally Advanced Malignant Solid NeoplasmMetastatic Solid TumorBreast Cancer+ [2]
Inactive Indication-
Originator Organization
TYK Medicines, Inc.TYK Medicines, Inc.Startup
Active Organization
TYK Medicines, Inc.TYK Medicines, Inc.Startup
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with TY-0540
NCT06246071
/ RecruitingPhase 1
A Phase Ia/Ib, Multicenter, Open-label Study of TYK-00540, Administered Orally in Adult Patients With Locally Advanced/Metastatic Solid Tumors
CTR20233663
/ RecruitingPhase 1
一项评价CDK2/4/6抑制剂TYK-00540片在晚期实体瘤患者中安全性、耐受性、药代动力学及有效性的Ia/Ib期临床研究
[Translation] A Phase Ia/Ib clinical study evaluating the safety, tolerability, pharmacokinetics and efficacy of the CDK2/4/6 inhibitor TYK-00540 tablets in patients with advanced solid tumors
100 Clinical Results associated with TY-0540
Login to view more data
100 Translational Medicine associated with TY-0540
Login to view more data
100 Patents (Medical) associated with TY-0540
Login to view more data
100 Deals associated with TY-0540
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Locally Advanced Malignant Solid NeoplasmPhase 1
CN
TYK Medicines, Inc.TYK Medicines, Inc.Startup
02 Jan 2024
Metastatic Solid TumorIND Approval
CN
TYK Medicines, Inc.TYK Medicines, Inc.Startup
08 Feb 2025
Breast CancerIND Approval
CN
TYK Medicines, Inc.TYK Medicines, Inc.Startup
08 Sep 2023
Pancreatic CancerIND Approval
CN
TYK Medicines, Inc.TYK Medicines, Inc.Startup
08 Sep 2023
Prostatic CancerIND Approval
CN
TYK Medicines, Inc.TYK Medicines, Inc.Startup
08 Sep 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free